| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |